Identification of a low molecular weight inhibitor of osteoblast mitogenesis in uremic plasma
- 1 May 1991
- journal article
- Published by Elsevier in Kidney International
- Vol. 39 (5) , 942-945
- https://doi.org/10.1038/ki.1991.118
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Plasma insulin-like growth factors and bone formation in uremic hyperparathyroidismKidney International, 1989
- Production of Mammastatin, a Tissue-Specific Growth Inhibitor, by Normal Human Mammary CellsScience, 1989
- Insulin-Like Growth Factor I Has Independent Effects on Bone Matrix Formation and Cell Replication*Endocrinology, 1988
- Isolation and Characterization of Insulin-Like Growth Factor I (Somatomedin-C) from Cultures of Fetal Rat Calvariae*Endocrinology, 1988
- Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro.The Journal of cell biology, 1987
- Regulation by Growth Hormone of Number of Chondrocytes Containing IGF-I in Rat Growth PlateScience, 1986
- A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chainsNature, 1986
- Somatomedin Inhibitor in Uremia*Journal of Clinical Endocrinology & Metabolism, 1984
- Inhibitor of marrow thymidine incorporation from sera of patients with uremiaKidney International, 1980
- Nutrition and Somatomedin. VI. Somatomedin Activity and Somatomedin Inhibitory Activity in Sera from Normal and Diabetic Rats*Endocrinology, 1979